Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Platinum-Treated Extensive Stage Small Cell Lung Cancer
NCT00182689Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2005
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Jul 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00182689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182689.